2023 - Research.com Biology and Biochemistry in Switzerland Leader Award
Pascal Schneider mostly deals with Cell biology, B-cell activating factor, Immunology, B cell and Receptor. His Cell biology study combines topics from a wide range of disciplines, such as Inhibitor of apoptosis, Apoptosis, Death domain and Caspase 8. His study in BAFF receptor and B cell homeostasis falls under the purview of B-cell activating factor.
He has researched BAFF receptor in several fields, including B-Cell Maturation Antigen, Marginal zone and Transmembrane activator and CAML interactor. His work carried out in the field of B cell brings together such families of science as CD23, Lymphocyte and CD40. In Receptor, he works on issues like Immune system, which are connected to Homology, Structural motif, Structural biology, Protein family and Laminin.
His primary areas of investigation include Cell biology, B-cell activating factor, Receptor, Immunology and Antibody. His research in Cell biology intersects with topics in Apoptosis, Programmed cell death, Fas receptor and Immune system. B cell covers Pascal Schneider research in B-cell activating factor.
The various areas that Pascal Schneider examines in his Receptor study include Tumor necrosis factor alpha, Molecular biology, Cancer research and Pharmacology. His studies deal with areas such as Peptide sequence and Ligand as well as Molecular biology. His research ties Cytotoxic T cell and Immunology together.
The scientist’s investigation covers issues in Cell biology, B-cell activating factor, Immunology, Receptor and Cancer research. Signal transduction is the focus of his Cell biology research. B cell and Antibody are all intrinsically tied to his study in B-cell activating factor.
As part of the same scientific family, Pascal Schneider usually focuses on Immunology, concentrating on Systemic lupus erythematosus and intersecting with Autoantibody. His research integrates issues of Tumor necrosis factor alpha, Cell culture, Antigen, Molecular biology and B-Cell Maturation Antigen in his study of Receptor. His Cancer research study deals with Immune system intersecting with Cytotoxic T cell and Homeostasis.
Pascal Schneider mainly investigates Cell biology, Immunology, B-cell activating factor, Receptor and Tumor necrosis factor alpha. Pascal Schneider has included themes like Ectodysplasin A, Acquired immune system, Fas ligand, Apoptosis and Integrin in his Cell biology study. The concepts of his Immunology study are interwoven with issues in Cancer research and Signal transduction.
His research on B-cell activating factor is centered around B cell and Genetics. As a member of one scientific family, Pascal Schneider mostly works in the field of Receptor, focusing on Cell culture and, on occasion, Cell, Avidity and Molecular biology. His BAFF receptor research includes themes of Plasma protein binding, B-Cell Maturation Antigen and Transmembrane activator and CAML interactor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inhibition of death receptor signals by cellular FLIP
Martin Irmler;Margot Thome;Michael Hahne;Pascal Schneider.
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
Nils Holler;Rossana Zaru;Olivier Micheau;Margot Thome.
Nature Immunology (2000)
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
Fabienne Mackay;Stephen A. Woodcock;Pornsri Lawton;Christine Ambrose.
Journal of Experimental Medicine (1999)
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
M. Hahne;D. Rimoldi;M. Schröter;P. Romero.
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
Margot Thome;Pascal Schneider;Kay Hofmann;Helmut Fickenscher.
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.
Pascal Schneider;Fabienne Mackay;Véronique Steiner;Kay Hofmann.
Journal of Experimental Medicine (1999)
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.
Isabelle Viard;Philippe Wehrli;Roberto Bullani;Pascal Schneider.
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
James E. Vince;W. Wei-Lynn Wong;Nufail Khan;Rebecca Feltham.
BAFF AND APRIL: a tutorial on B cell survival.
Fabienne Mackay;Pascal Schneider;Paul Rennert;Jeffrey Browning.
Annual Review of Immunology (2003)
BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF
Jeffrey S. Thompson;Sarah A. Bixler;Fang Qian;Kalpit Vora.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: